Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 34,285 shares at $32.33 ($1.1M) on 2024-03-01, disclosed to the SEC on 2024-03-01.
Open-market sale of $1.1M PTGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.61 | 7,850 | $240K | 22.3% |
| 2 | $30.61 | 7,850 | $240K | 22.3% |
| 3 | $31.00 | 2,089 | $65K | 6.0% |
| 4 | $32.22 | 12,000 | $387K | 35.9% |
| 5 | $32.33 | 2,248 | $73K | 6.7% |
| 6 | $32.33 | 2,248 |
| $73K |
| 6.7% |
| Total | $31.42 avg | 34,285 | $1.1M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-27 | $2.6M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $3.8M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |